Khuntikeo N, Titapun A, Chamadol N, Boonphongsathien W, Sa-Ngiamwibool P, Taylor-Robinson SD, Wadsworth CA, Zhang S, Kardoulaki EM, Young IR, Syms RRA

Hepatic Medicine: Evidence and Research 2020, 12:29-39

Published Date: 24 March 2020

Original Research

Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells

Aravalli RN, Collins DP, Hapke JH, Crane AT, Steer CJ

Hepatic Medicine: Evidence and Research 2020, 12:15-27

Published Date: 13 February 2020

Review

Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions

Mehrotra S, Lalwani S, Nundy S

Hepatic Medicine: Evidence and Research 2020, 12:1-13

Published Date: 23 January 2020

Review

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis

Ganguli S, DeLeeuw P, Satapathy SK

Hepatic Medicine: Evidence and Research 2019, 11:159-178

Published Date: 15 November 2019

Original Research

Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study

Azarkar G, Doosti Z, Osmani F, Ziaee M

Hepatic Medicine: Evidence and Research 2019, 11:153-158

Published Date: 25 October 2019

Short Report

Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes

Page K, Qeadan F, Qualls C, Thornton K, Arora S

Hepatic Medicine: Evidence and Research 2019, 11:149-152

Published Date: 7 October 2019

Original Research

Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital

Goa A, Dana T, Bitew S, Arba A

Hepatic Medicine: Evidence and Research 2019, 11:137-147

Published Date: 6 September 2019

Review

Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives

Omar HH

Hepatic Medicine: Evidence and Research 2019, 11:131-136

Published Date: 3 September 2019

Review

“Let my liver rather heat with wine” - a review of hepatic fibrosis pathophysiology and emerging therapeutics

Moscoso CG, Steer CJ

Hepatic Medicine: Evidence and Research 2019, 11:109-129

Published Date: 2 September 2019

Review

Severe alcoholic hepatitis: current perspectives

Philips CA, Augustine P, Yerol PK, Rajesh S, Mahadevan P

Hepatic Medicine: Evidence and Research 2019, 11:97-108

Published Date: 8 August 2019

Original Research

The effect of a mesenchymal stem cell conditioned medium fraction on morphological characteristics of hepatocytes in acetaminophen-induced acute liver failure: a preliminary study

Temnov A, Rogov K, Zhalimov V, Igor P, Pekov S, Bader A, Sklifas A, Giri S

Hepatic Medicine: Evidence and Research 2019, 11:89-96

Published Date: 19 July 2019

Review

Lysosomal acid lipase deficiency – early diagnosis is the key

Strebinger G, Müller E, Feldman A, Aigner E

Hepatic Medicine: Evidence and Research 2019, 11:79-88

Published Date: 23 May 2019

Original Research

Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain

Abdulla M, Ali H, Nass H, Khamis J, AlQamish J

Hepatic Medicine: Evidence and Research 2019, 11:69-78

Published Date: 13 May 2019

Original Research

Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population

Alsaleh M, Barbera TA, Reeves HL, Cramp ME, Ryder S, Gabra H, Nash K, Shen YL, Holmes E, Williams R, Taylor-Robinson SD

Hepatic Medicine: Evidence and Research 2019, 11:47-67

Published Date: 3 May 2019

Review

Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?

Kornerup LS, Pflugrad H, Weissenborn K, Vilstrup H, Dam G

Hepatic Medicine: Evidence and Research 2019, 11:41-46

Published Date: 18 March 2019

Original Research

Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection

Bernstein D, Tripathi R, Cohen DE

Hepatic Medicine: Evidence and Research 2019, 11:35-40

Published Date: 13 February 2019

Review

Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options

Philips CA, Rajesh S, Augustine P, Padsalgi G, Ahamed R

Hepatic Medicine: Evidence and Research 2019, 11:23-34

Published Date: 25 January 2019

Review

Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies

Marciano S, Diaz JM, Dirchwolf M, Gadano A

Hepatic Medicine: Evidence and Research 2019, 11:13-22

Published Date: 14 January 2019

Perspectives

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder

Roncero C, Ryan P, Littlewood R, Macías J, Ruiz J, Seijo P, Palma-Alvarez RF, Vega P

Hepatic Medicine: Evidence and Research 2019, 11:1-11

Published Date: 24 December 2018

Clinical Trial Report

Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure

Duan Z, Xin S, Zhang J, You S, Chen Y, Liu H, Zheng S, Li Z, Ashley R, Millis M

Hepatic Medicine: Evidence and Research 2018, 10:139-152

Published Date: 16 November 2018

Original Research

Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease

Ahmed Z, Ren J, Gonzalez A, Ahmed U, Walayat S, Martin DK, Moole H, Yong S, Koppe S, Dhillon S

Hepatic Medicine: Evidence and Research 2018, 10:133-138

Published Date: 24 October 2018

Expert Opinion

Expert opinion on the management of hepatitis C infection in Kuwait

Saad MF, Alenezi S, Asker H

Hepatic Medicine: Evidence and Research 2018, 10:117-132

Published Date: 28 September 2018

Review

Acute pediatric hyperammonemia: current diagnosis and management strategies

Savy N, Brossier D, Brunel-Guitton C, Ducharme-Crevier L, Du Pont-Thibodeau G, Jouvet P

Hepatic Medicine: Evidence and Research 2018, 10:105-115

Published Date: 12 September 2018

Review

Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment

Gunaydin M, Bozkurter Cil AT

Hepatic Medicine: Evidence and Research 2018, 10:95-104

Published Date: 10 September 2018

Original Research

Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications

Tawfik AK, Helmy A, Yousef M, Abou-Saif S, Kobtan A, Asaad E, Abd-Elsalam S

Hepatic Medicine: Evidence and Research 2018, 10:87-93

Published Date: 4 September 2018

Original Research

Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment

Abou Rached A, Abou Kheir S, Saba J, Assaf S, Kassis G, Sanchez Gonzalez Y, Ethgen O

Hepatic Medicine: Evidence and Research 2018, 10:73-85

Published Date: 28 August 2018

Review

Management of refractory cirrhotic ascites: challenges and solutions

Fukui H, Kawaratani H, Kaji K, Takaya H, Yoshiji H

Hepatic Medicine: Evidence and Research 2018, 10:55-71

Published Date: 3 July 2018

Review

Biomarkers for primary biliary cholangitis: current perspectives

Kouroumalis E, Samonakis D, Voumvouraki A

Hepatic Medicine: Evidence and Research 2018, 10:43-53

Published Date: 18 June 2018

Review

Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy

Sulejmani N, Jafri SM

Hepatic Medicine: Evidence and Research 2018, 10:33-42

Published Date: 4 May 2018

Original Research

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial

Alam S, Ghosh J, Mustafa G, Kamal M, Ahmad N

Hepatic Medicine: Evidence and Research 2018, 10:23-31

Published Date: 27 April 2018

Review

Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies

Mendes LC, Stucchi RSB, Vigani AG

Hepatic Medicine: Evidence and Research 2018, 10:13-22

Published Date: 3 April 2018

Review

Hepatic encephalopathy: current challenges and future prospects

Swaminathan M, Ellul MA, Cross TJS

Hepatic Medicine: Evidence and Research 2018, 10:1-11

Published Date: 22 March 2018

Original Research

Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort

Kutala BK, Mouri F, Castelnau C, Bouton V, Giuily N, Boyer N, Asselah T, Marcellin P

Hepatic Medicine: Evidence and Research 2017, 9:67-73

Published Date: 18 December 2017

Review

PNPLA3 expression and its impact on the liver: current perspectives

Bruschi FV, Tardelli M, Claudel T, Trauner M

Hepatic Medicine: Evidence and Research 2017, 9:55-66

Published Date: 6 November 2017

Original Research

Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement

Tag-Adeen M, Sabra AM, Akazawa Y, Ohnita K, Nakao K

Hepatic Medicine: Evidence and Research 2017, 9:45-53

Published Date: 6 October 2017

Original Research

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy

Roggeri DP, Roggeri A

Hepatic Medicine: Evidence and Research 2017, 9:37-43

Published Date: 25 September 2017

Corrigendum

Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum]

Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I

Hepatic Medicine: Evidence and Research 2017, 9:35-36

Published Date: 26 July 2017

Original Research

Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt

Omar MZ, Metwally MA, El-Feky HM, Ahmed IA, Ismail MA, Idris A

Hepatic Medicine: Evidence and Research 2017, 9:27-33

Published Date: 14 June 2017

Review

Hepatitis C infection in Egypt: prevalence, impact and management strategies

Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I

Hepatic Medicine: Evidence and Research 2017, 9:17-25

Published Date: 15 May 2017

Review

Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C

Naylor PH, Mutchnick M

Hepatic Medicine: Evidence and Research 2017, 9:13-16

Published Date: 16 March 2017

Original Research

Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain

Abdulla MA, Murad EA, Aljenaidi HA, Aljowder DR, Aljeeran OIK, Farid E, Al Qamish JR

Hepatic Medicine: Evidence and Research 2017, 9:7-11

Published Date: 1 March 2017

Review

Unresectable hepatoblastoma: current perspectives

Trobaugh-Lotrario AD, Meyers RL, O'Neill AF, Feusner JH

Hepatic Medicine: Evidence and Research 2017, 9:1-6

Published Date: 1 February 2017

Original Research

Knowledge and attitude of health care professionals regarding hepatitis B virus infection and its vaccination, University of Gondar Hospital, Ethiopia

Ayalew MB, Horssa BA, Getachew N, Amare S, Getnet A

Hepatic Medicine: Evidence and Research 2016, 8:135-142

Published Date: 13 December 2016

Original Research

Targeted transplantation of mitochondria to hepatocytes

Gupta N, Wu CH, Wu GY

Hepatic Medicine: Evidence and Research 2016, 8:115-134

Published Date: 29 November 2016

Review

Defibrotide in the treatment of hepatic veno-occlusive disease

Fulgenzi A, Ferrero ME

Hepatic Medicine: Evidence and Research 2016, 8:105-113

Published Date: 31 October 2016

Original Research

Presence and consequence of tooth periapical radiolucency in patients with cirrhosis

Grønkjær LL, Holmstrup P, Schou S, Schwartz K, Kongstad J, Jepsen P, Vilstrup H

Hepatic Medicine: Evidence and Research 2016, 8:97-103

Published Date: 13 September 2016

Review

Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection

Bowlus CL

Hepatic Medicine: Evidence and Research 2016, 8:89-95

Published Date: 1 September 2016

Review

Idiopathic noncirrhotic portal hypertension: current perspectives

Riggio O, Gioia S, Pentassuglio I, Nicoletti V, Valente M, d’Amati G

Hepatic Medicine: Evidence and Research 2016, 8:81-88

Published Date: 27 July 2016

Review

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection

Sundaram V, Kowdley KV

Hepatic Medicine: Evidence and Research 2016, 8:75-80

Published Date: 28 June 2016

Original Research

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Baur J, Ritter CO, Germer CT, Klein I, Kickuth R, Steger U

Hepatic Medicine: Evidence and Research 2016, 8:69-74

Published Date: 20 June 2016

Review

Paritaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise review

Hussaini T

Hepatic Medicine: Evidence and Research 2016, 8:61-68

Published Date: 18 May 2016

Review

Hepatitis C in the Russian Federation: challenges and future directions

Mukomolov S, Trifonova G, Levakova I, Bolsun D, Krivanogova E

Hepatic Medicine: Evidence and Research 2016, 8:51-60

Published Date: 5 May 2016

Review

The pathophysiology of thrombocytopenia in chronic liver disease

Mitchell O, Feldman DM, Diakow M, Sigal SH

Hepatic Medicine: Evidence and Research 2016, 8:39-50

Published Date: 15 April 2016

Review

Autophagy: a new target for nonalcoholic fatty liver disease therapy

Mao YQ, Yu FJ, Wang JB, Guo CY, Fan XM

Hepatic Medicine: Evidence and Research 2016, 8:27-37

Published Date: 24 March 2016

Review

Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

Pol S, Corouge M, Vallet-Pichard A

Hepatic Medicine: Evidence and Research 2016, 8:21-26

Published Date: 4 March 2016

Review

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response

Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T

Hepatic Medicine: Evidence and Research 2016, 8:9-20

Published Date: 22 February 2016

Review

Challenging hepatitis C-infected liver transplant patients

Oliver M, Chiodo Ortiz C, Ortiz J

Hepatic Medicine: Evidence and Research 2016, 8:1-8

Published Date: 18 January 2016

Original Research

Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil

Fabrício-Silva GM, Poschetzky BS, Perez RM, Santos RC, Cavalini LT, Porto LC

Hepatic Medicine: Evidence and Research 2015, 7:71-79

Published Date: 2 November 2015

Review

Interferon-free combination therapies for the treatment of hepatitis C: current insights

Holmes JA, Thompson AJ

Hepatic Medicine: Evidence and Research 2015, 7:51-70

Published Date: 2 November 2015

Review

Management options in decompensated cirrhosis

Shah NL, Banaei YP, Hojnowski KL, Cornella SL

Hepatic Medicine: Evidence and Research 2015, 7:43-50

Published Date: 15 July 2015

Original Research

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs

Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M

Hepatic Medicine: Evidence and Research 2015, 7:37-42

Published Date: 13 July 2015

Original Research

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease

Kawanaka M, Nishino K, Oka T, Urata N, Nakamura J, Suehiro M, Kawamoto H, Chiba Y, Yamada G

Hepatic Medicine: Evidence and Research 2015, 7:29-35

Published Date: 3 June 2015

Case Series

Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients

Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M

Hepatic Medicine: Evidence and Research 2015, 7:21-27

Published Date: 19 May 2015

Review

Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?

Janardhan SV, Reau NS

Hepatic Medicine: Evidence and Research 2015, 7:11-20

Published Date: 16 April 2015

Review

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility

Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M

Hepatic Medicine: Evidence and Research 2015, 7:1-10

Published Date: 13 April 2015

Review

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?

Lim TR

Hepatic Medicine: Evidence and Research 2014, 6:113-118

Published Date: 3 December 2014

Review

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients

Vander Naalt SJ, Gurria JP, Holterman AXL

Hepatic Medicine: Evidence and Research 2014, 6:103-112

Published Date: 29 October 2014

Original Research

Systemic vascular resistance in cirrhosis: a predictor of severity?

Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq H, Ihimoyan A

Hepatic Medicine: Evidence and Research 2014, 6:95-101

Published Date: 6 August 2014

Review

Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis

Yoshimitsu K

Hepatic Medicine: Evidence and Research 2014, 6:89-94

Published Date: 3 July 2014

Review

Ending hepatitis C in the United States: the role of screening

Coffin PO, Reynolds A

Hepatic Medicine: Evidence and Research 2014, 6:79-87

Published Date: 3 July 2014

Review

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents

Kamal SM

Hepatic Medicine: Evidence and Research 2014, 6:61-77

Published Date: 24 June 2014

Review

Transmission, diagnosis, and management of hepatitis E: an update

Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J

Hepatic Medicine: Evidence and Research 2014, 6:45-59

Published Date: 3 June 2014

Review

Hepatitis C in Argentina: epidemiology and treatment

Gaite LA, Marciano S, Galdame OA, Gadano AC

Hepatic Medicine: Evidence and Research 2014, 6:35-43

Published Date: 27 May 2014

Review

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives

Degasperi E, Aghemo A

Hepatic Medicine: Evidence and Research 2014, 6:25-33

Published Date: 29 April 2014

Review

A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events

Hughes AN, Oxford JT

Hepatic Medicine: Evidence and Research 2014, 6:15-23

Published Date: 6 March 2014

Case Series

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis

Chua DL, Hahambis T, Sigal SH

Hepatic Medicine: Evidence and Research 2014, 6:11-14

Published Date: 29 January 2014

Review

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease

Bradford V, Dillon JF, Miller MH

Hepatic Medicine: Evidence and Research 2014, 6:1-10

Published Date: 11 December 2013

Case report

A case of hepatic portal venous gas due to viral gastroenteritis

Mirmanesh M, Nguyen QS, Markelov A

Hepatic Medicine: Evidence and Research 2013, 5:63-65

Published Date: 21 October 2013

Review

Novel drugs in the management of difficult-to-treat hepatitis C genotypes

Cartwright EJ, Miller L

Hepatic Medicine: Evidence and Research 2013, 5:53-61

Published Date: 20 August 2013

Original Research

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients

Durango E, Dietrich C, Seitz HK, Kunz CU, Pomier-Layrargues GT, Duarte-Rojo A, Beaton M, Elkhashab M, Myers RP, Mueller S

Hepatic Medicine: Evidence and Research 2013, 5:43-52

Published Date: 4 July 2013

Original Research

The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage

Ehnert S, Lukoschek T, Bachmann A, Martinez Sanchez JJ, Damm G, Nussler NC, Pscherer S, Stöckle U, Dooley S, Mueller S, Nussler AK

Hepatic Medicine: Evidence and Research 2013, 5:31-41

Published Date: 22 March 2013

Review

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia

Danish FA, Yasmin S

Hepatic Medicine: Evidence and Research 2013, 5:17-30

Published Date: 15 March 2013

Original Research

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study

Kawanaka M, Nishino K, Nakamura J, Suehiro M, Goto D, Urata N, Oka T, Kawamoto H, Nakamura H, Yodoi J, Hino K, Yamada G

Hepatic Medicine: Evidence and Research 2013, 5:11-16

Published Date: 4 March 2013

Review

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine

Lau T, Ahmad J

Hepatic Medicine: Evidence and Research 2013, 5:1-10

Published Date: 11 February 2013

Review

Natural history and management of primary biliary cirrhosis

Al-Harthy N, Kumagi T

Hepatic Medicine: Evidence and Research 2012, 4:61-71

Published Date: 4 December 2012

Original Research

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina

Espul C, Benedetti L, Cuello H, Houillon G, Rasuli A

Hepatic Medicine: Evidence and Research 2012, 4:53-60

Published Date: 28 August 2012

Case report

Acute hepatic failure in pediatric H1N1 infection: a case report from Al-Adan Hospital, Kuwait

Al-Refaee F

Hepatic Medicine: Evidence and Research 2012, 4:49-51

Published Date: 18 July 2012

Review

Update on entecavir in the management of severe forms of Hepatitis B

Sacco R

Hepatic Medicine: Evidence and Research 2012, 4:39-47

Published Date: 15 May 2012

Review

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics

Dhanasekaran R, Limaye A, Cabrera R

Hepatic Medicine: Evidence and Research 2012, 4:19-37

Published Date: 8 May 2012

Original Research

Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites

Kohlhaas A, Durango E, Millonig G, Bastard C, Sandrin L, Golriz M, Mehrabi A, Büchler MW, Seitz HK, Mueller S

Hepatic Medicine: Evidence and Research 2012, 4:11-18

Published Date: 1 May 2012

Review

Epidemiology and treatment of autoimmune hepatitis

Francque S, Vonghia L, Ramon A, Michielsen P

Hepatic Medicine: Evidence and Research 2012, 4:1-10

Published Date: 16 March 2012

Review

Rifaximin in the treatment of hepatic encephalopathy

Iadevaia MD, Del Prete A, Cesaro C, Gaeta L, Zulli C, Loguercio C

Hepatic Medicine: Evidence and Research 2011, 3:109-117

Published Date: 22 December 2011

Short Report

A newborn liver mass that never existed: a somber reminder of embryonic ties between umbilical vein and portal venous system

Haafiz A, Williams JL, Andres JM, Novak DA

Hepatic Medicine: Evidence and Research 2011, 3:107-108

Published Date: 14 December 2011

Original Research

Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program

Cervio G, Trentadue J, D´Agostino DE, Luque C, Giorgi MA, Armoni J, Debbag R

Hepatic Medicine: Evidence and Research 2011, 3:99-106

Published Date: 19 September 2011

Original Research

Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH

Darwiche H, Oh S-H, Steiger-Luther NC, Williams JM, Pintilie DG, Shupe TD, Petersen BE

Hepatic Medicine: Evidence and Research 2011, 3:89-98

Published Date: 5 September 2011

Review

Autonomic dysfunction in chronic liver disease

Frith J, Newton JL

Hepatic Medicine: Evidence and Research 2011, 3:81-87

Published Date: 23 August 2011

Review

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies

Ismail MH, Pinzani M

Hepatic Medicine: Evidence and Research 2011, 3:69-80

Published Date: 4 July 2011

Original Research

Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection

Obienu O, Nwokediuko SC

Hepatic Medicine: Evidence and Research 2011, 3:63-68

Published Date: 30 June 2011

Review

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients

Locke JE, Singer AL

Hepatic Medicine: Evidence and Research 2011, 3:53-62

Published Date: 13 May 2011

Original Research

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Tomiyama Y, Yoshioka N, Yanai Y, Kawase T, Nishina S, Hara Y, Yoshida K, Korenaga K, Korenaga M, Hino K

Hepatic Medicine: Evidence and Research 2011, 3:45-52

Published Date: 26 April 2011

Review

Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis

Kent AP, Stylianou IM

Hepatic Medicine: Evidence and Research 2011, 3:29-44

Published Date: 8 April 2011

Review

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus

Bruno S, Savojardo D, Almasio PL, Mondelli MU

Hepatic Medicine: Evidence and Research 2011, 3:21-28

Published Date: 30 March 2011

Erratum

Xiao N, Shi S, Zhuang H

Hepatic Medicine: Evidence and Research 2011, 3:19-20

Published Date: 18 March 2011

Original Research

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis

Suad Abdeen, Samuel O Olusi, Sunila George

Hepatic Medicine: Evidence and Research 2011, 3:13-18

Published Date: 10 March 2011

Review

Pathogenesis and management of alcoholic liver cirrhosis: a review

Yi-Wen Huang, Sien-Sing Yang, Jia-Horng Kao

Hepatic Medicine: Evidence and Research 2011, 3:1-11

Published Date: 24 December 2010

Review

Update on new approaches in the management of hepatocellular carcinoma

Giuseppe Cabibbo, Michela Antonucci, Chiara Genco

Hepatic Medicine: Evidence and Research 2010, 2:163-172

Published Date: 26 November 2010

Original Research

Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection

RM Mukherjee, P Balkumar Reddy, Jyothi Arava, et al

Hepatic Medicine: Evidence and Research 2010, 2:157-162

Published Date: 16 November 2010

Review

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma

Jen-Jung Pan, Milind Javle, Mie Mie Thinn, et al

Hepatic Medicine: Evidence and Research 2010, 2:147-155

Published Date: 2 November 2010

Review

Potential treatment options and future research to increase hepatitis C virus treatment response rate

Veronica TenCate, Bruno Sainz Jr, Scott J Cotler, et al

Hepatic Medicine: Evidence and Research 2010, 2:125-145

Published Date: 1 October 2010

Review

Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine

Liang Wang

Hepatic Medicine: Evidence and Research 2010, 2:111-124

Published Date: 17 August 2010

Original Research

A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection

Nan Xiao, Shuang Shi, Hui Zhuang

Hepatic Medicine: Evidence and Research 2010, 2:99-109

Published Date: 28 July 2010

Review

Optimal management of hepatorenal syndrome in patients with cirrhosis

Paolo Angeli, Filippo Morando

Hepatic Medicine: Evidence and Research 2010, 2:87-98

Published Date: 21 June 2010

Anti-inflammatory action of insulin via induction of Gadd45-β transcription by the mTOR signaling pathway

Katherine D Bortoff, Adam B Keeton, J Lee Franklin, et al

Hepatic Medicine: Evidence and Research 2010, 2:79-85

Published Date: 24 June 2010

Original Research

Mice with null mutation of Ceacam1 develop nonalcoholic steatohepatitis

Sumona Ghosh, Meenakshi Kaw, Payal R Patel, et al

Hepatic Medicine: Evidence and Research 2010, 2:69-78

Published Date: 31 May 2010

Review

Liver stiffness: a novel parameter for the diagnosis of liver disease

Sebastian Mueller, Laurent Sandrin

Hepatic Medicine: Evidence and Research 2010, 2:49-67

Published Date: 25 May 2010

Perspectives

Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes

Katherine S Koch, Hyam L Leffert

Hepatic Medicine: Evidence and Research 2010, 2:39-47

Published Date: 23 March 2010

Review

Mechanism of the inhibitory effect of ghrelin in sepsis

Asha Jacob, Rongqian Wu, Mian Zhou, et al

Hepatic Medicine: Evidence and Research 2010, 2:33-38

Published Date: 23 February 2010

Original Research

Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model

Nicole C Steiger-Luther, Houda Darwiche, Seh-Hoon Oh, et al

Hepatic Medicine: Evidence and Research 2010, 2:13-32

Published Date: 3 February 2010

Original Research

Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes

Kathleen Ponzetti, Melissa King, Anna Gates, et al

Hepatic Medicine: Evidence and Research 2010, 2:1-11

Published Date: 11 January 2010

Original Research

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors

M Gabrovska, F Geurs, S Ponette, et al

Hepatic Medicine: Evidence and Research 2009, 1:9-12

Published Date: 30 October 2009

Original Research

A high prevalence of extreme hyperferritinemia in acute hepatitis patients

Kazuhiro Kotoh, Akihiro Ueda, Masatake Tanaka, et al.

Hepatic Medicine: Evidence and Research 2009, 1:1-7

Published Date: 14 September 2009